{"id":"W4392359260","doi":"10.17650/1726-9776-2023-19-4-32-43","title":"Survival by depth of response and efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma: analysis of the phase 3 randomized CLEAR study","year":2023,"lang":"en","type":"article","venue":"Cancer Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"","keywords":"Lenvatinib; Medicine; Sunitinib; Renal cell carcinoma; Pembrolizumab; Oncology; Internal medicine; Subgroup analysis; Carcinoma; Cancer; Immunotherapy; Meta-analysis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007752495,0.0007172464,0.002049882,0.0003977921,0.000251257,0.0007035288,0.001033739,0.0007730584,0.001365174],"category_scores_gemma":[0.003501352,0.0003252401,0.004079727,0.0004694249,0.000490599,0.0006490976,0.0007573778,0.001678431,0.0001581117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008851789,"about_ca_system_score_gemma":0.001290233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009649667,"about_ca_topic_score_gemma":0.002612889,"domain_scores_codex":[0.9958656,0.003046155,0.0001794749,0.0004017592,0.0003408986,0.0001660647],"domain_scores_gemma":[0.9968081,0.0009430957,0.0009956113,0.0003797216,0.0001607294,0.0007126491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9168773,0.002241038,0.05406765,0.0004321781,0.0100909,0.0000614033,0.0001081777,0.001524221,0.003456553,0.0001517596,0.001044934,0.009943916],"study_design_scores_gemma":[0.4445333,0.1564302,0.3713389,0.0001310189,0.01362405,0.0002863491,0.0002045807,0.006549616,0.003080393,0.000750905,0.002958923,0.0001116838],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995665,0.00176036,0.0003093554,0.0001931064,0.00003183222,0.0006293791,0.00102651,0.00001615593,0.0003683449],"genre_scores_gemma":[0.9957244,0.0003430704,0.0006336586,0.0002466186,0.00006703189,0.000891677,0.001806106,0.00001012126,0.0002773108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007752495,"threshold_uncertainty_score":0.04099959,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03375832532127623,"score_gpt":0.3233777834645756,"score_spread":0.2896194581432994,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}